Secondary immunodeficiency

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
2 Unique IMPs
1 Commercial trials
Drug classes (ATC)
J Anti-infectives (ATC J) 1
L Oncology (ATC L) 1
Mechanism of action (INN-stem analysis)
Immunoglobulin 1 substance
Monoclonal antibody (rat) 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Takeda Development Center Americas Inc. Commercial
    HUMAN NORMAL IMMUNOGLOBULIN; TECLISTAMAB
    2024-518420-80-00 12 countries n=172
    Pending
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Takeda Development Center Americas Inc. Commercial 1 Phase III 0
← All indication landscapes